Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
32.63 AUD | -0.85% | +0.18% | +28.30% |
Evolution of the average Target Price on ResMed Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering ResMed Inc.
KeyBanc Capital Markets | |
Jefferies & Co. | |
Oppenheimer | |
JPMorgan Chase | |
Mizuho Securities | |
Needham & Co. | |
Morgan Stanley | |
RBC Capital Markets | |
Evans & Partners | |
UBS | |
BofA Securities | |
Wolfe Research | |
JMP Securities | |
Citigroup | |
Goldman Sachs | |
Baird | |
Macquarie | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- RMD Stock
- RMD Stock
- Consensus ResMed Inc.